Symmetric dimethylarginine is a stronger predictor of mortality risk than asymmetric dimethylarginine among older people with kidney disease. [electronic resource]
- Annals of clinical biochemistry 05 2019
- 367-374 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1758-1001
10.1177/0004563218822655 doi
Aged Aged, 80 and over Arginine--analogs & derivatives Biomarkers--blood Cohort Studies Female Glomerular Filtration Rate Humans Male Renal Insufficiency, Chronic--blood Risk Assessment